Launch of generic Spiriva Handihaler by Lupin Pharmaceuticals

Launch of generic Spiriva Handihaler by Lupin Pharmaceuticals 

Spiriva Handihaler (Tiotropium Bromide) has recently been released and is FDA approved. 

Tiotropium bromide inhalation powder is indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Tiotropium bromide inhalation powder is indicated to reduce exacerbations in COPD patients. 

Lupin Pharmaceuticals, Inc. manufactures Tiotropium bromide inhalation powder. 

Tiotropium bromide inhalation powder capsules contain 18 mcg of tiotropium per capsule. 

 

 

The post Launch of generic Spiriva Handihaler by Lupin Pharmaceuticals appeared first on Carlisle Medical.